SBE-β-CD

Catalog No.S4592 Batch:S459201

Print

Technical Data

Formula

C42H70-nO35.nNa.n(C4H8O3S)

Molecular Weight CAS No. 182410-00-0
Solubility (25°C)* In vitro Water 100 mg/mL
DMSO Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Biological Activity

Description SBE-β-CD is a novel, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs.

Protocol (from reference)

References

  • https://pubmed.ncbi.nlm.nih.gov/32376442/

Selleck's SBE-β-CD has been cited by 31 publications

H3K36me2 methyltransferase NSD2/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy [ Autophagy, 2025, 21(8):1824-1842] PubMed: 40097917
Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models [ Int J Mol Sci, 2025, 26(2)490] PubMed: 39859206
Unique compound with anti-allergic action: inhibition of Lyn kinase activity by KIRA6 [ Front Pharmacol, 2025, 16:1625798] PubMed: 40786050
CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome [ Sci Rep, 2025, 15(1):7224] PubMed: 40021701
An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs [ Nat Commun, 2024, 15(1):5703] PubMed: 38977662
EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401 [ Cell Death Differ, 2024, 31(10):1318-1332] PubMed: 38789573
EGFR inhibits TNF-α-mediated pathway by phosphorylating TNFR1 at tyrosine 360 and 401 [ Cell Death Differ, 2024, 10.1038/s41418-024-01316-3] PubMed: 38789573
Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment [ Oncogene, 2024, 10.1038/s41388-024-03231-w] PubMed: 39639170
PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity [ Nat Commun, 2023, 14(1):2806] PubMed: 37193698
Harnessing PROTAC technology to combat stress hormone receptor activation [ Nat Commun, 2023, 14(1):8177] PubMed: 38071198

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.